Premium
FluoroPharma Medical Inc (CE) (FPMI)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
MORGANTOWN, W. Va., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea"), a leader in the field of bioanalytics, announced today that Thijs Spoor and Josiah T. Austin have...
MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
MONTCLAIR, N.J., July 26, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
MONTCLAIR, N.J., June 18, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough molecular imaging products that utilize...
MONTCLAIR, N.J., June 15, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
BOSTON, May 31, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron...
BOSTON, March 19, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI) today announces that BFPET, its imaging agent for measuring cardiovascular blood flow, has been granted patent...
BOSTON, March 1, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron...
BOSTON, Jan. 13, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, today...
BOSTON, Dec. 30, 2011 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI) is pleased to announce that Lawrence Atinsky has been appointed to the Board of Directors of FluoroPharma effective...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 3400 | 0.0001 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 15600 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 12950 | 0.0001 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 35614 | 0.0001 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0002 | 0.0001 | 27034 | 0.00010011 | CS |
| 156 | 0 | 0 | 0.0001 | 0.0052 | 0.0001 | 53891 | 0.00170202 | CS |
| 260 | -0.00441 | -97.7827050998 | 0.00451 | 0.079 | 1.0E-6 | 124681 | 0.01471934 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
